Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK233705B magnesium stearate inhalation in COPD
2006-006083-33Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing GSK233705B with Placebo (2 arms). Primary endpoints: General safety and tolerability, Adverse events and 9 more. Started Feb 2007; status: completed.
02
Drugs
darotropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-006083-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006083-33.